Senores Pharma.

55
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
1,091.35
-19 (-1.71%)
BSENSE

Nov 20

BSE+NSE Vol: 2.5 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
12
Operating Income
632.00
398.00
214.00
35.00
14.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
632.00
398.00
214.00
35.00
14.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
3.00
0.00
-2.00
Raw Materials Consumed
251.00
181.00
102.00
13.00
10.00
Power & Fuel Cost
10.00
9.00
2.00
0.00
0.00
Employee Cost
112.00
60.00
35.00
4.00
2.00
Operating Expenses
34.00
31.00
11.00
0.00
0.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
6.00
3.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
4.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
464.00
308.00
172.00
22.00
12.00
Operating Profit (PBDIT) excl Other Income
168.00
89.00
41.00
12.00
1.00
Other Income
47.00
19.00
2.00
3.00
0.00
Operating Profit (PBDIT)
215.00
108.00
44.00
16.00
2.00
Interest
25.00
21.00
9.00
2.00
0.00
Profit before Depriciation and Tax
190.00
87.00
34.00
14.00
1.00
Depreciation
31.00
16.00
10.00
1.00
0.00
Profit Before Taxation & Exceptional Items
159.00
70.00
24.00
12.00
1.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
159.00
70.00
24.00
12.00
1.00
Provision for Tax
37.00
12.00
-7.00
4.00
0.00
Profit After Tax
121.00
58.00
32.00
8.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
89.00
41.00
10.00
1.00
0.00
Profit Available for appropriations
205.00
100.00
41.00
10.00
1.00
Appropriations
205.00
100.00
41.00
10.00
1.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
26.39
16.12
13.67
8.87
1.81
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 58.85% vs 85.65% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 87.65% vs 115.68% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 16.15% vs 128.04% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 108.31% vs 78.36% in Mar 2025

Compare Profit and Loss Results of Senores Pharma.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
632.00
1,811.00
-1,179.00
-65.10%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
632.00
1,811.00
-1,179.00
-65.10%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-47.00
47.00
100.00%
Raw Materials Consumed
251.00
1,206.00
-955.00
-79.19%
Power & Fuel Cost
10.00
40.00
-30.00
-75.00%
Employee Cost
112.00
208.00
-96.00
-46.15%
Operating Expenses
34.00
50.00
-16.00
-32.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
79.00
-73.00
-92.41%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
25.00
-21.00
-84.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
464.00
1,637.00
-1,173.00
-71.66%
Operating Profit (PBDIT) excl Other Income
168.00
174.00
-6.00
-3.45%
Other Income
47.00
18.00
29.00
161.11%
Operating Profit (PBDIT)
215.00
192.00
23.00
11.98%
Interest
25.00
8.00
17.00
212.50%
Profit before Depriciation and Tax
190.00
184.00
6.00
3.26%
Depreciation
31.00
28.00
3.00
10.71%
Profit Before Taxation & Exceptional Items
159.00
155.00
4.00
2.58%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
159.00
155.00
4.00
2.58%
Provision for Tax
37.00
37.00
0.00
0.00%
Profit After Tax
121.00
118.00
3.00
2.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
89.00
286.00
-197.00
-68.88%
Profit Available for appropriations
205.00
404.00
-199.00
-49.26%
Appropriations
205.00
404.00
-199.00
-49.26%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
26.39
2.2
24.19
1,099.55%
Profit And Loss - Net Sales
Net Sales 632.63 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 58.85% vs 85.65% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 168.32 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 87.65% vs 115.68% in Mar 2025

Profit And Loss - Interest
Interest 25.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.15% vs 128.04% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 121.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 108.31% vs 78.36% in Mar 2025